NCT00239642View on ClinicalTrials.gov

Safety and Efficacy of Iron Sucrose in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

April 30, 2010

Conditions
AnemiaChronic Kidney Disease
Interventions
DRUG

Venofer (iron sucrose injection)

0.5 mg/kg of Venofer (iron sucrose) up to 100 mg administered intravenously

DRUG

Venofer (iron sucrose injection)

1.0 mg/kg of Venofer (iron sucrose) up to 100 mg administered intravenously

DRUG

Venofer (iron sucrose injection)

2.0 mg/kg of Venofer (iron sucrose) up to 100 mg administered intravenously

Trial Locations (1)

19403

Luitpold Pharmaceutials, Norristown

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY

NCT00239642 - Safety and Efficacy of Iron Sucrose in Children | Biotech Hunter | Biotech Hunter